Evidence map›Paper›PMID 39770625›Full record

ArticleMicroorganisms2024

Assessing Normandy Soil Microbial Diversity for Antibacterial Activities Using Traditional Culture and iChip Methods.

Fabien Perrier, Juliette Morice, Sabrina Gueulle, Antoine Géry, Eliette Riboulet-Bisson, David Garon, Cécile Muller, Florie Desriac

Abstract read
In one paragraph

Article in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Drug repurposing of natural depsipeptide fromFrontiers in pharmacology · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fabien PerrierUniversité de Caen Normandie, CBSA UR 4312, UFR des Sciences, Campus 1, F-14000 Caen, France.ORCID 0009-0006-8343-3486
Juliette MoriceUniversité de Caen Normandie, CBSA UR 4312, UFR des Sciences, Campus 1, F-14000 Caen, France.
Sabrina GueulleUniversité de Caen Normandie, CBSA UR 4312, UFR des Sciences, Campus 1, F-14000 Caen, France.
Antoine GéryUniversité de Caen Normandie, ToxEMAC-ABTE UR 4651, UFR des Sciences, Campus 1, F-14000 Caen, France.ORCID 0000-0002-3144-9260
Eliette Riboulet-BissonUniversité de Caen Normandie, CBSA UR 4312, UFR des Sciences, Campus 1, F-14000 Caen, France.ORCID 0000-0003-1205-2468
David GaronUniversité de Caen Normandie, ToxEMAC-ABTE UR 4651, UFR des Sciences, Campus 1, F-14000 Caen, France.ORCID 0000-0003-3545-6641
Cécile MullerUniversité de Caen Normandie, CBSA UR 4312, UFR des Sciences, Campus 1, F-14000 Caen, France.ORCID 0000-0003-3078-1920
Florie DesriacUniversité de Caen Normandie, CBSA UR 4312, UFR des Sciences, Campus 1, F-14000 Caen, France.

Funding

Université de Caen Normandie PhD thesis
6 · The paper itself

Abstract

Uncultured microorganisms represent a promising and untapped source of antibacterial compounds, crucial in the fight against the significant threat of antimicrobial resistance (AMR). In this study, both traditional and isolation chip (iChip) cultivation techniques were employed to enhance the recovery of known and unknown microorganisms from soils located in Normandy, France. The isolates obtained were identified using 16S rDNA or ITS regions analysis and MALDI-TOF mass spectrometry and were screened for antibacterial activity. A total of 386 isolates, belonging to 6 microbial phyla and distributed across 65 genera, were recovered using both methods. In total, 11 isolates are potentially new bacterial species, and 34 were associated with 22 species described recently. The iChip method yielded a higher diversity of microorganisms (47 genera) than the traditional method (38 genera) and was particularly effective in enriching

Indexed as

antibacterial activityantimicrobial resistancefungiiChipin situ cultivationmicrobial natural productuncultured bacteria

Identifiers

PMID39770625
PMCPMC11679952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.